1. Home
  2. LOAN vs ARMP Comparison

LOAN vs ARMP Comparison

Compare LOAN & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LOAN
  • ARMP
  • Stock Information
  • Founded
  • LOAN 1989
  • ARMP N/A
  • Country
  • LOAN United States
  • ARMP United States
  • Employees
  • LOAN N/A
  • ARMP N/A
  • Industry
  • LOAN Real Estate Investment Trusts
  • ARMP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LOAN Real Estate
  • ARMP Health Care
  • Exchange
  • LOAN Nasdaq
  • ARMP Nasdaq
  • Market Cap
  • LOAN 61.5M
  • ARMP 52.1M
  • IPO Year
  • LOAN 1999
  • ARMP N/A
  • Fundamental
  • Price
  • LOAN $5.49
  • ARMP $2.54
  • Analyst Decision
  • LOAN
  • ARMP Strong Buy
  • Analyst Count
  • LOAN 0
  • ARMP 1
  • Target Price
  • LOAN N/A
  • ARMP $9.00
  • AVG Volume (30 Days)
  • LOAN 23.8K
  • ARMP 13.2K
  • Earning Date
  • LOAN 07-22-2025
  • ARMP 08-12-2025
  • Dividend Yield
  • LOAN 8.42%
  • ARMP N/A
  • EPS Growth
  • LOAN N/A
  • ARMP N/A
  • EPS
  • LOAN 0.48
  • ARMP N/A
  • Revenue
  • LOAN $7,300,469.00
  • ARMP $4,699,000.00
  • Revenue This Year
  • LOAN N/A
  • ARMP $8.43
  • Revenue Next Year
  • LOAN $4.47
  • ARMP N/A
  • P/E Ratio
  • LOAN $11.44
  • ARMP N/A
  • Revenue Growth
  • LOAN N/A
  • ARMP 14.24
  • 52 Week Low
  • LOAN $4.74
  • ARMP $0.90
  • 52 Week High
  • LOAN $6.05
  • ARMP $2.96
  • Technical
  • Relative Strength Index (RSI)
  • LOAN 53.57
  • ARMP 65.04
  • Support Level
  • LOAN $5.40
  • ARMP $2.14
  • Resistance Level
  • LOAN $5.54
  • ARMP $2.61
  • Average True Range (ATR)
  • LOAN 0.17
  • ARMP 0.14
  • MACD
  • LOAN -0.01
  • ARMP -0.00
  • Stochastic Oscillator
  • LOAN 42.30
  • ARMP 81.08

About LOAN Manhattan Bridge Capital Inc

Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

Share on Social Networks: